April 3, 2013
Among a significant percentage of patients, the risk of metastasis of cancer is particularly expressed by the presence of an abnormal amount of protein HER2 on the surface of cancer cells.
A new in vitro system for identification of these proteins in diseased tissues. has been developed by EPFL and Institute of Pathology at the Lausanne University Hospital (CHUV) scientists. It is extremely fast, precise, inexpensive, and… read more